Genome-wide study identifies PTPRO and WDR72 and FOXQ1-SUMO1P1 interaction associated with neurocognitive function

Journal of Psychiatric Research

Volumn 46, Issue 2, 2012, Pages 271-278

  LeBlanc, Marissa ^a,b   Kulle, Bettina ^a,b   Sundet, Kjetil ^b,c   Agartz, Ingrid ^c,d   Melle, Ingrid ^b,c   Djurovic, Srdjan ^c   Frigessi, Arnoldo ^b,e   Andreassen, Ole A ^b,c  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d DIAKONHJEMMET HOSPITAL   (Norway)

^e (sfi) Statistics for Innovation   (Norway)

Author keywords

Forkhead box Q1 (FOXQ1); GWAS; Neurocognition; O (PTPRO); Protein tyrosine phosphatase; Receptor type; SUMO1 pseudogene 1 (SUMO1P1); WD repeat domain 72 (WDR72)

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; PROTEIN TYROSINE PHOSPHATASE; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR FOXQ1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASE PAIRING; BIPOLAR DISORDER; CHROMOSOME ANALYSIS; COGNITION; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; GENDER; GENE DOSAGE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENOME ANALYSIS; GENOTYPE; HUMAN; INTRON; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PSEUDOGENE; PSYCHOMOTOR ACTIVITY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84855988047     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.11.001     Document Type: Article

References (74)

1. Amer.Psych.Assoc Diagnostic and statistical manual of mental disorders 2010, APA, Washington, DC.
2. Arguello P.A., Gogos J.A. Cognition in mouse models of schizophrenia susceptibility genes. Schizophrenia Bulletin 2010, 36:289-300.
3. Athanasiu L., Mattingsdal M., Kahler A.K., Brown A., Gustafsson O., Agartz I., et al. Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. Journal of Psychiatric Research 2010, 44:748-753.
4. Balter M. Evolution of behavior. Did working memory spark creative culture?. Science 2010, 328:160-163.
5. Bates T.C., Price J.F., Harris S.E., Marioni R.E., Fowkes F.G., Stewart M.C., et al. Association of KIBRA and memory. Neuroscience Letters 2009, 458:140-143.
6. Beltran P.J., Bixby J.L., Masters B.A. Expression of PTPRO during mouse development suggests involvement in axonogenesis and differentiation of NT-3 and NGF-dependent neurons. Journal of Comparative Neurology 2003, 456:384-395.
7. Bieller A., Pasche B., Frank S., Glaser B., Kunz J., Witt K., et al. Isolation and characterization of the human forkhead gene FOXQ1. DNA and Cell Biology 2001, 20:555-561.
8. Birkenaes A.B., Opjordsmoen S., Brunborg C., Engh J.A., Jonsdottir H., Ringen P.A., et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. Journal of Clinical Psychiatry 2007, 68:917-923.
9. Bodden K., Bixby J.L. CRYP-2: a receptor-type tyrosine phosphatase selectively expressed by developing vertebrate neurons. Journal of Neurobiology 1996, 31:309-324.
10. Bora E., Yucel M., Pantelis C. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. British Journal of Psychiatry 2009, 195:475-482.
11. Bouchard T.J., Lykken D.T., McGue M., Segal N.L., Tellegen A. Sources of human psychological differences: the Minnesota study of twins reared apart. Science 1990, 250:223-228.
12. Burdick K.E., DeRosse P., Kane J.M., Lencz T., Malhotra A.K. Association of genetic variation in the MET proto-oncogene with schizophrenia and general cognitive ability. American Journal of Psychiatry 2010, 167:436-443.
13. Butcher L.M., Davis O.S., Craig I.W., Plomin R. Genome-wide quantitative trait locus association scan of general cognitive ability using pooled DNA and 500K single nucleotide polymorphism microarrays. Genes, Brain and Behavior 2008, 7:435-446.
14. Cirulli E.T., Kasperaviciute D., Attix D.K., Need A.C., Ge D., Gibson G., et al. Common genetic variation and performance on standardized cognitive tests. European Journal of Human Genetics 2010, 18:815-820.
15. Coleman W.L., Bykhovskaia M. Rab3a-mediated vesicle recruitment regulates short-term plasticity at the mouse diaphragm synapse. Molecular and Cellular Neuroscience 2009, 41:286-296.
16. Cordell H.J. Detecting gene-gene interactions that underlie human diseases. Nature Reviews Genetics 2009, 10:392-404.
17. Crawley J.N. Behavioral phenotyping strategies for mutant mice. Neuron 2008, 57:809-818.
18. Davies G., Tenesa A., Payton A., Yang J., Harris S.E., Liewald D., et al. Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Molecular Psychiatry 2011, 16:996-1005.
19. Delis D.C., Kramer J.H., Kaplan E., Ober B.A. California verbal learning test - second edition (CVLT-II). Norwegian manual supplement 2004, Pearson Assessment, Stockholm.
20. Delis D.C., Kaplan E., Kramer J.H. Delis - Kaplan executive function system (D-KEFS) Norwegian manual 2005, Pearson Assessment, Stockholm.
21. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:6917-6922.
22. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
23. Eisenberg D.P., Berman K.F. Executive function, neural circuitry, and genetic mechanisms in schizophrenia. Neuropsychopharmacology 2010, 35:258-277.
24. Enard W., Przeworski M., Fisher S.E., Lai C.S., Wiebe V., Kitano T., et al. Molecular evolution of FOXP2, a gene involved in speech and language. Nature 2002, 418:869-872.
25. Finkel D., Pedersen N.L., McGue M., McClearn G.E. Heritability of cognitive abilities in adult twins: comparison of Minnesota and Swedish data. Behavior Genetics 1995, 25:421-431.
26. Geschwind D.H. Advances in autism. Annual Review of Medicine 2009, 60:367-380.
27. Gonzalez-Brito M.R., Bixby J.L. Protein tyrosine phosphatase receptor type O regulates development and function of the sensory nervous system. Molecular and Cellular Neuroscience 2009, 42:458-465.
28. Green A.E., Munafo M.R., DeYoung C.G., Fossella J.A., Fan J., Gray J.R. Using genetic data in cognitive neuroscience: from growing pains to genuine insights. Nature Reviews Neuroscience 2008, 9:710-720.
29. Greene C.M., Braet W., Johnson K.A., Bellgrove M.A. Imaging the genetics of executive function. Biological Psychology 2008, 79:30-42.
30. Haatveit B.C., Sundet K., Hugdahl K., Ueland T., Melle I., Andreassen O.A. The validity of d prime as a working memory index: results from the " Bergen n-back task" Journal of Clinical and Experimental Neuropsychology 2010, 32:871-880.
31. Hower A.E., Beltran P.J., Bixby J.L. Dimerization of tyrosine phosphatase PTPRO decreases its activity and ability to inactivate TrkC. Journal of Neurochemistry 2009, 110:1635-1647.
32. Hubener M., Bonhoeffer T. Searching for engrams. Neuron 2010, 67:363-371.
33. Huentelman M.J., Papassotiropoulos A., Craig D.W., Hoerndli F.J., Pearson J.V., Huynh K.D., et al. Calmodulin-binding transcription activator 1 (CAMTA1) alleles predispose human episodic memory performance. Human Molecular Genetics 2007, 16:1469-1477.
34. Kalechstein A.D., Newton T.F., van Gorp W.G. Neurocognitive functioning is associated with employment status: a quantitative review. Journal of Clinical and Experimental Neuropsychology 2003, 25:1186-1191.
35. Katoh M., Katoh M. Human FOX gene family. International Journal of Oncology 2004, 25:1495-1500. [Review].
36. Kløve H. Clinical neuropsychology. The medical clinics of North America 1963, Saunders, New York. F.M. Forster (Ed.).
37. Kotani T., Murata Y., Ohnishi H., Mori M., Kusakari S., Saito Y., et al. Expression of PTPRO in the interneurons of adult mouse olfactory bulb. Journal of Comparative Neurology 2010, 518:119-136.
38. Kurtzer I., Scott S.H. Amulti-level approach to understanding upper limb function. Progress in Brain Research 2007, 165:347-362.
39. Levy J.A., Chelune G.J. Cognitive-behavioral profiles of neurodegenerative dementias: beyond Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology 2007, 20:227-238.
40. Lott I.T., Dierssen M. Cognitive deficits and associated neurological complications in individuals with Down's syndrome. Lancet Neurology 2010, 9:623-633.
41. McClearn G.E., Johansson B., Berg S., Pedersen N.L., Ahern F., Petrill S.A., et al. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 1997, 276:1560-1563.
42. Meyers J.E., Meyers K.R. Rey complex figure test and recognition trial 1995, Psychological Assessment Resources, Inc., Odessa, FL.
43. Minzenberg M.J., Laird A.R., Thelen S., Carter C.S., Glahn D.C. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Archives of General Psychiatry 2009, 66:811-822.
44. Need A.C., Attix D.K., McEvoy J.M., Cirulli E.T., Linney K.L., Hunt P., et al. Agenome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. Human Molecular Genetics 2009, 18:4650-4661.
45. Need A.C., Attix D.K., McEvoy J.M., Cirulli E.T., Linney K.N., Wagoner A.P., et al. Failure to replicate effect of Kibra on human memory in two large cohorts of European origin. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B:667-668.
46. Nicodemus K.K., Callicott J.H., Higier R.G., Luna A., Nixon D.C., Lipska B.K., et al. Evidence of statistical epistasis between DISC1, CIT and NDEL1 impacting risk for schizophrenia: biological validation with functional neuroimaging. Human Genetics 2010, 127:453-454.
47. Papassotiropoulos A., Stephan D.A., Huentelman M.J., Hoerndli F.J., Craig D.W., Pearson J.V., et al. Common Kibra alleles are associated with human memory performance. Science 2006, 314:475-478.
48. Porteous D.J., Thomson P., Brandon N.J., Millar J.K. The genetics and biology of DISC1 - an emerging role in psychosis and cognition. Biological Psychiatry 2006, 60:123-131.
49. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 2007, 81:559-575.
50. Rimol L.M., Agartz I., Djurovic S., Brown A.A., Roddey J.C., Kahler A.K., et al. Sex-dependent association of common variants of microcephaly genes with brain structure. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:384-388.
51. Robinson L.J., Ferrier I.N. Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disorders 2006, 8:103-116.
52. Safran M., Dalah I., Alexander J., Rosen N., Iny S.T., Shmoish M., et al. GeneCards version 3: the human gene integrator 2010, Database. Oxford.
53. Sakisaka T., Takai Y. Purification and properties of rabconnectin-3. Methods in Enzymology 2005, 403:401-407.
54. Sanders S., Keck-Waggoner C.L., Zimonjic D.B., Popescu N.C., Thorgeirsson S.S. Assignment of WDR7 (alias TRAG, TGF-beta resistance associated gene) to orthologous regions of human chromosome 18q21.1→q22 and mouse chromosome 18D.1-E.3 by fluorescence in situ hybridization. Cytogenetics and Cell Genetics 2000, 88:324-325.
55. Scott S.H. Inconvenient truths about neural processing in primary motor cortex. Journal of Physiology 2008, 586:1217-1224.
56. Seshadri S., DeStefano A.L., Au R., Massaro J.M., Beiser A.S., Kelly-Hayes M., et al. Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham study. BMC Medical Genetics 2007, 8(Suppl. 1):S15.
57. Shintani T., Ihara M., Sakuta H., Takahashi H., Watakabe I., Noda M. Eph receptors are negatively controlled by protein tyrosine phosphatase receptor type O. Nature Neuroscience 2006, 9:761-769.
58. Silva A.J., Zhou Y., Rogerson T., Shobe J., Balaji J. Molecular and cellular approaches to memory allocation in neural circuits. Science 2009, 326:391-395.
59. Simonsen C., Sundet K., Vaskinn A., Birkenaes A.B., Engh J.A., Faerden A., et al. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. Schizophrenia Bulletin 2009.
60. Spitzer R.L., Williams J.B., Gibbon M., First M.B. The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Archives of General Psychiatry 1992, 49:624-629.
61. Spitzer R.L., Williams J.B., Kroenke K., Linzer M., deGruy F.V., Hahn S.R., et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 1994, 272:1749-1756.
62. Stepanek L., Stoker A.W., Stoeckli E., Bixby J.L. Receptor tyrosine phosphatases guide vertebrate motor axons during development. Journal of Neuroscience 2005, 25:3813-3823.
63. Sundet K., Vaskinn A. Estimating premorbid IQ. Journal of the Norwegian Psychological Association 2008, 45:1108-1115. [in Norwegian with English abstract].
64. Tagawa M., Shirasawa T., Yahagi Y., Tomoda T., Kuroyanagi H., Fujimura S., et al. Identification of a receptor-type protein tyrosine phosphatase expressed in postmitotic maturing neurons: its structure and expression in the central nervous system. Biochemical Journal 1997, 321:865-871.
65. Tan H.Y., Callicott J.H., Weinberger D.R. Prefrontal cognitive systems in schizophrenia: towards human genetic brain mechanisms. Cognitive Neuropsychiatry 2009, 14:277-298.
66. Tan H.Y., Chen Q., Sust S., Buckholtz J.W., Meyers J.D., Egan M.F., et al. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:12536-12541.
67. Thomas P.E., Wharram B.L., Goyal M., Wiggins J.E., Holzman L.B., Wiggins R.C. GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein-tyrosine phosphatase. Identification, molecular cloning, and characterization in rabbit. Journal of Biological Chemistry 1994, 269:19953-19962.
68. Thompson R.F. The neurobiology of learning and memory. Science 1986, 233:941-947.
69. Toulopoulou T., Picchioni M., Rijsdijk F., Hua-Hall M., Ettinger U., Sham P., et al. Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples. Archives of General Psychiatry 2007, 64:1348-1355.
70. Vassos E., Bramon E., Picchioni M., Walshe M., Filbey F.M., Kravariti E., et al. Evidence of association of KIBRA genotype with episodic memory in families of psychotic patients and controls. Journal of Psychiatric Research 2010, 44:795-798.
71. Ventura J., Liberman R.P., Green M.F., Shaner A., Mintz J. Training and quality assurance with the structured clinical interview for DSM-IV (SCID-I/P). Psychiatry Research 1998, 79:163-173.
72. Wechsler D. Wechsler adult intelligence scale - third edition (WAIS-III). Norwegian manual 2003, Pearson Assessment, Stockholm.
73. Wechsler D. Wechsler abbreviated scale of intelligence (WASI). Norwegian manual supplement 2007, Pearson Assessment, Stockholm.
74. Wechsler D. Wechsler memory scale - third edition (WMS-III). Norwegian manual 2007, Pearson Assessment, Stockholm.